| 摘要 |
A multiple coagulation test system and method for determining an appropria te coagulation promoting substance for administration to a patient as a therapy for improving clotting function in said patient has at least three sample wells. One of th e wells is for testing a baseline clotting indicator time of a patient's blood to serve as a contro l sample. Each of the other wells are for testing clotting indicator times of different coagulation promoting substances when mixed with the patient's blood. The coagulation promoting substances are agents or combination of agents capable of improving clotting function in th e patient. An appropriate therapy for improving clotting function in the patient is determined by comparison of the baseline control clotting indicator time with the clotting indicator times of the coagulation promoting substances mixed with the patient's blood. Generally, the agent giving the lowest clotting indicator time is selected as an appropriate treatment for reducing hemorrhaging begun. Utilizing the inventive system eliminates the need to us e a multiple agent approach, by identifying the most effective course of action in a rapi d manner. The system and method are also easily adaptable to test coagulation inhibiting substances.
|
